Manufacturer of Controlled Substances; Notice of Registration; Siemens Healthcare Diagnostics, Inc., 31390 [2012-12822]

Download as PDF 31390 Federal Register / Vol. 77, No. 102 / Friday, May 25, 2012 / Notices DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Pcas-Nanosyn, LLC By Notice dated January 30, 2012, and published in the Federal Register on February 6, 2012, 77 FR 5847, PCASNanosyn, LLC, 3331–B Industrial Drive, Santa Rosa, California 95403, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: May 15, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–12820 Filed 5–24–12; 8:45 am] BILLING CODE 4410–09–P Schedule Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Phencyclidine (7471) .................... Codeine (9050) ............................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Morphine (9300) ........................... Oxymorphone (9652) ................... Fentanyl (9801) ............................ DEPARTMENT OF JUSTICE II II II II II II II II II II II II Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Siemens Healthcare Diagnostics, Inc. The company is a contract manufacturer. At the request of the company’s customers, it manufactures derivatives of controlled substances in bulk form only. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of PCAS-Nanosyn, LLC. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated PCAS-Nanosyn, LLC. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the By Notice dated January 26, 2012, and published in the Federal Register on February 6, 2012, 77 FR 5847, Siemens Healthcare Diagnostics Inc., 100 GBC Drive, Mail Stop 514, Newark, Delaware 19702, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Tetrahydrocannabinols (7370) ..... Ecgonine (9180) ........................... Morphine (9300) ........................... I II II The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator controls which are DEA exempt products. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Siemens Healthcare Diagnostics Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Siemens Healthcare Diagnostics Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: May 15, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–12822 Filed 5–24–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Sigma Aldrich Research Biochemicals, Inc. By Notice dated January 26, 2012, and published in the Federal Register on February 6, 2012, 77 FR 5847, Sigma Aldrich Research Biochemicals, Inc., 1– 3 Strathmore Road, Natick, Massachusetts 01760–2447, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: mstockstill on DSK4VPTVN1PROD with NOTICES Drug Schedule Cathinone (1235) ......................................................................................................................................................................................... Methcathinone (1237) .................................................................................................................................................................................. 4-methyl-N-methylcathinone (1248) ............................................................................................................................................................ Aminorex (1585) .......................................................................................................................................................................................... Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... Lysergic acid diethylamide (7315) ............................................................................................................................................................... 3,4-methylenedioxypyrovalerone (7535) ..................................................................................................................................................... 3,4-methylenedioxy-N-methylcathinone (7540) ........................................................................................................................................... Tetrahydrocannabinols (7370) ..................................................................................................................................................................... 4–Bromo-2,5-dimethoxyamphetamine (7391) ............................................................................................................................................. 4–Bromo-2,5-dimethoxyphenethylamine (7392) ......................................................................................................................................... 2,5–Dimethoxyamphetamine (7396) ........................................................................................................................................................... 3,4–Methylenedioxyamphetamine (7400) ................................................................................................................................................... N–Hydroxy-3,4-methylenedioxyamphetamine (7402) ................................................................................................................................. 3,4–Methylenedioxy-N-ethylamphetamine (7404) ....................................................................................................................................... 3,4–Methylenedioxymethamphetamine (7405) ........................................................................................................................................... Psilocybin (7437) ......................................................................................................................................................................................... VerDate Mar<15>2010 17:55 May 24, 2012 Jkt 226001 PO 00000 Frm 00101 Fmt 4703 Sfmt 4703 E:\FR\FM\25MYN1.SGM 25MYN1 I I I I I I I I I I I I I I I I I

Agencies

[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Page 31390]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12822]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Siemens Healthcare Diagnostics, Inc.

    By Notice dated January 26, 2012, and published in the Federal 
Register on February 6, 2012, 77 FR 5847, Siemens Healthcare 
Diagnostics Inc., 100 GBC Drive, Mail Stop 514, Newark, Delaware 19702, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the following basic 
classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Ecgonine (9180)............................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to produce the listed controlled substances in 
bulk to be used in the manufacture of reagents and drug calibrator 
controls which are DEA exempt products.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Siemens Healthcare Diagnostics Inc., to manufacture the listed basic 
classes of controlled substances is consistent with the public interest 
at this time. DEA has investigated Siemens Healthcare Diagnostics Inc., 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-12822 Filed 5-24-12; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.